Creating Asthma Measurements through the MORRE Study

Trial Objective

Creating Asthma Measurements through the MORRE StudyResearchers want to develop new ways to measure if a patient’s asthma is improving or worsening. During the study, participants will use a FitBit® to measure steps per day and sleep quality. Participants also will answer a custom survey using their own smartphone. Researchers hope to determine the best ways to show how well asthma is controlled while being treated with omalizumab, a common asthma medication.

Enrollment

Active Clinical Trials Currently Recruiting

Who Can Participate

Participants between 18 and 85 years of age with moderate-to-severe asthma at the time of enrollment, and who are eligible for omalizumab therapy.

Age: 18-85    Gender: Any Gender


Estimated Time Commitment

13 months and 4 clinic visits that must be completed at the National Jewish Health main campus



Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Chris Houser
303.398.1911

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

National Jewish Health

Co-Investigators


Request More Information

By completing this form, you agree to learn more about this study, see if you qualify and receive periodic updates about clinical research via email.


*
*
*
*